scispace - formally typeset
S

Sungkwon Chung

Researcher at Sungkyunkwan University

Publications -  72
Citations -  1908

Sungkwon Chung is an academic researcher from Sungkyunkwan University. The author has contributed to research in topics: Patch clamp & Substantia nigra. The author has an hindex of 24, co-authored 72 publications receiving 1697 citations. Previous affiliations of Sungkwon Chung include Northwestern University & Chung-Ang University.

Papers
More filters
Journal ArticleDOI

Presenilin-mediated modulation of capacitative calcium entry.

TL;DR: Reduced CCE is most likely an early cellular event leading to increased Abeta42 generation associated with FAD mutant presenilins, indicating that the CCE pathway is a novel therapeutic target for Alzheimer's disease.
Journal ArticleDOI

Presenilin mutations linked to familial Alzheimer's disease cause an imbalance in phosphatidylinositol 4,5-bisphosphate metabolism.

TL;DR: The data suggest that PIP2 imbalance may contribute to Alzheimer's disease pathogenesis by affecting multiple cellular pathways, such as the generation of toxic Aβ42 as well as the activity of the MIC/TRPM7 channel, which has been linked to other neurodegenerative conditions.
Journal ArticleDOI

The neuroprotective effect of modified Yeoldahanso-tang via autophagy enhancement in models of Parkinson's disease

TL;DR: Modified Yeoldahanso-tang treatment has neuroprotective effects that are partially mediated by autophagy enhancement that may be a promising herbal formula for the prevention and treatment of neurodegenerative diseases, especially PD.
Journal ArticleDOI

Effect of ginsenosides, active components of ginseng, on capsaicin-induced pain-related behavior.

TL;DR: The results suggest that ginsenosides produce antinociceptive effects through their action at the spinal and/or supraspinal site(s), not at nociceptors in the periphery, and that these effects are not mediated by opioid receptors.
Journal ArticleDOI

O-GlcNAcylation promotes non-amyloidogenic processing of amyloid-β protein precursor via inhibition of endocytosis from the plasma membrane.

TL;DR: O-GlcNAcylation promotes the plasma membrane localization of AβPP, which enhances the non-amyloidogenic processing of A βPP, and can be a potential therapeutic strategy for Alzheimer's disease.